Colon cancer care and survival: income and insurance are more predictive in the USA, community primary care physician supply more so in Canada

International Journal for Equity in Health

Volumn 14, Issue 1, 2015, Pages

  Gorey, Kevin M ^a   Kanjeekal, Sindu M ^b   Wright, Frances C ^c   Hamm, Caroline ^b   Luginaah, Isaac N ^d   Bartfay, Emma ^e   Zou, Guangyong ^f   Holowaty, Eric J ^c   Richter, Nancy L ^a  

^a UNIVERSITY OF WINDSOR   (Canada)

^b WESTERN UNIVERSITY   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

^e UNIVERSITY OF ONTARIO INSTITUTE OF TECHNOLOGY   (Canada)

^f ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

Canada; Colon cancer care; Gastroenterologists; Health care reform; Health insurance; Patient protection and affordable care act; Poverty; Primary care physicians; Survival; United States

Indexed keywords

CANCER; CENSUS; GASTROENTERITIS; HEALTH INSURANCE; INCOME DISTRIBUTION; POVERTY; PREDICTION; PRIMARY HEALTH CARE; REGRESSION ANALYSIS; SOCIOECONOMIC STATUS; SPATIOTEMPORAL ANALYSIS; SURVIVAL;

ADULT; AGED; ARTICLE; CANADA; CANCER SURVIVAL; COHORT ANALYSIS; COLON CANCER; CONTROLLED STUDY; FEMALE; GASTROENTEROLOGIST; GENERAL PRACTITIONER; HEALTH CARE PERSONNEL MANAGEMENT; HEALTH INSURANCE; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PATIENT CARE; POVERTY; PREDICTIVE VALUE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SOCIOECONOMICS; SURVIVAL PREDICTION; SURVIVAL TIME; UNITED STATES; CALIFORNIA; COLONIC NEOPLASMS; ECONOMICS; EPIDEMIOLOGY; GASTROENTEROLOGY; HEALTH CARE DISPARITY; INSURANCE; MANPOWER; MORTALITY; ONTARIO; SUPPLY AND DISTRIBUTION;

CALIFORNIA; CANADA; ONTARIO [CANADA]; UNITED STATES;

CALIFORNIA; COLONIC NEOPLASMS; GASTROENTEROLOGY; HEALTHCARE DISPARITIES; HUMANS; INSURANCE COVERAGE; ONTARIO; PHYSICIANS, PRIMARY CARE;

EID: 84946061028     PISSN: None     EISSN: 14759276     Source Type: Journal    
DOI: 10.1186/s12939-015-0246-z     Document Type: Article

References (79)

1. Gorey KM, Richter NL, Luginaah IN, Hamm C, Holowaty EJ, Zou GY, et al. Breast cancer among women living in poverty: Better care in Canada than in the United States. Soc Work Res. 2015;39:107-18.
2. Gorey KM, Luginaah IN, Holowaty EJ, Fung KY, Hamm C. Breast cancer survival in Ontario and California, 1998-2006: Socioeconomic inequity remains much greater in the United States. Ann Epidemiol. 2009;19:121-4.
3. Gorey KM, Kliewer E, Holowaty EJ, Laukkanen E, Ng EY. An international comparison of breast cancer survival: Winnipeg, Manitoba and Des Moines, Iowa, metropolitan areas. Ann Epidemiol. 2003;13:32-41.
4. Gorey KM, Holowaty EJ, Fehringer G, Laukkanen E, Richter NL, Meyer CM. An international comparison of cancer survival: Metropolitan Toronto, Ontario and Honolulu, Hawaii. Am J Public Health. 2000;90:1866-72.
5. Gorey KM, Holowaty EJ, Fehringer G, Laukkanen E, Moskowitz A, Webster DJ, et al. An international comparison of cancer survival: Toronto, Ontario, and Detroit, Michigan, metropolitan areas. Am J Public Health. 1997;87:1156-63.
6. Jargowsky PA. Concentration of poverty in the new millennium: Changes in prevalence, composition, and location of high poverty neighborhoods. New York: The Century Foundation and Rutgers Center for Urban Research and Education; 2013.
7. Wilson WJ. The truly disadvantaged: The inner city, the underclass, and public policy, 2nd ed. University of Chicago Press; 2012
8. Kneebone E, Nadeau C, Berube A. The re-emergence of concentrated poverty: Metropolitan trends in the 2000s. Washington: The Brookings Institution; 2011.
9. Gorey KM, Luginaah IN, Holowaty EJ, Zou G, Hamm C, Balagurusamy MK. Mediation of the effects of living in extremely poor neighborhoods by health insurance: Breast cancer care in California, 1996 to 2011. Int J Equity Health. 2013;12:6.
10. Starfield B. Reinventing primary care: Lessons from Canada for the United States. Health Aff (Millwood). 2010;29:1030-6.
11. Starfield B. Commentary: How does 'insurance' improve equity in health? Int J Epidemiol. 2009;38:1551-3.
12. Gorey KM. Breast cancer survival in Canada and the United States: Meta-analytic evidence of a Canadian advantage in low-income areas. Int J Epidemiol. 2009;38:1543-51.
13. Gorey KM, Luginaah IN, Bartfay E, Fung KY, Holowaty EJ, Wright FC, et al. Associations of physician supplies with colon cancer care in Ontario and California, 1996 to 2006. Dig Dis Sci. 2011;56:523-31.
14. Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, et al. Global surveillance of cancer survival 1995-2009: Analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015;385:977-1010.
15. Anderson RN, Kohler BA, Eheman CR, Ward EM. Annual report to the nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer. 2014;120:1290-314.
16. Gorey KM, Luginaah IN, Bartfay E, Zou GY, Haji-Jama S, Holowaty EJ, et al. Better colon cancer care for extremely poor Canadian women compared with American women. Health Soc Work. 2013;38:240-8.
17. Canadian Cancer Society's Steering Committee on Cancer Statistics. Canadian cancer statistics 2012. Toronto: Canadian Cancer Society; 2012.
18. Gillis A, Dixon M, Smith A, Law C, Coburn NG. A patient-centred approach toward surgical wait times for colon cancer: a population-based analysis. Can J Surg. 2014;57:94-100.
19. Tan J, Muir J, Coburn N, Singh S, Hodgson D, Saskin R, et al. Surveillance patterns after curative-intent colorectal cancer surgery in Ontario. Can J Gastroenterol Hepatol. 2014;28:427-33.
20. Torabi M, Green C, Nugent Z, Mahmud SM, Demers AA, Griffith J, et al. Geographical variation and factors associated with colorectal cancer mortality in a universal health care system. Can J Gastroenterol Hepatol. 2014;28:191-7.
21. Dubecz A, Solymosi N, Schweigert M, Stadlhuber RJ, Peters JH, Ofner D, et al. Time trends and disparities in lymphadenectomy for gastrointestinal cancer in the United States: A population-based analysis of 326,243 patients. J Gastrointest Surg. 2013;17:611-9.
22. Rayson D, Urquhart R, Cox M, Grunfeld E, Porter G. Adherence to clinical practice guidelines for adjuvant chemotherapy for colorectal cancer in a Canadian province: A population-based analysis. J Oncol Pract. 2012;8:253-60.
23. Hines RB, Barrett A, Twumasi-Ankrah P, Broccoli D, Engelman KK, Baranda J, et al. Predictors of guideline treatment nonadherence and the impact on survival in patients with colorectal cancer. J Natl Compr Canc Netw. 2015;13:51-60.
24. Warren JL, Butler EN, Stevens J, Lathan CS, Noone AM, Ward KC, et al. Receipt of chemotherapy among Medicare patients with cancer by type of supplemental insurance. J Clin Oncol. 2015;33:312-8.
25. Dawes AJ, Louie R, Nguyen DK, Maggard-Gibbons M, Parikh P, Ettner SL, et al. The impact of continuous Medicaid enrollment on diagnosis, treatment, and survival in six surgical cancers. Health Serv Res. 2014;49:1787-811.
26. Hines R, Markossian T, Johnson A, Dong F, Bayakly R. Geographic residency status and census tract socioeconomic status as determinants of colorectal cancer outcomes. Am J Public Health. 2014;104:e63-71.
27. Boland GM, Chang GJ, Haynes AB, Chiang YJ, Chagpar R, Xing Y, et al. Association between adherence to National Comprehensive Cancer Network treatment guidelines and improved survival in patients with colon cancer. Cancer. 2013;119:1593-601.
28. Modiri A, Makipour K, Gomez J, Friedenberg F. Predictors of colorectal cancer testing using the California Health Inventory Survey. World J Gastroenterol. 2013;19:1247-55.
29. Etzioni DA, El-Khoueiry AB, Beart RW. Rates and predictors of chemotherapy use for stage III colon cancer: A systematic review. Cancer. 2008;113:3279-89.
30. Figueredo A, Coombes ME, Mukherjee S. Adjuvant therapy for completely resected stage II colon cancer. Cochrane Database Syst Rev. 2008;4.
31. Roetzheim RG, Gonzalez EC, Ramirez A, Campbell R, Van Durme DJ. Primary care physician supply and colorectal cancer. J Fam Pract. 2001;50:1027-31.
32. Roetzheim RG, Pal N, Gonzalez EC, Ferrante JM, Van Durme DJ, Ayanian JZ, et al. The effects of physician supply on the early detection of colorectal cancer. J Fam Pract. 1999;48:850-8.
33. Starfield B, Shi L, Grover A, Macinko J. The effects of specialist supply on populations' health: Assessing the evidence. Health Aff (Millwood). 2005;W5:97-107.
34. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG. AJCC cancer staging manual. 6th ed. New York: Springer; 2002.
35. North American Association of Central Cancer Registries. Data quality assessments, 2014. Springfield: NAACCR; 2015.
36. Weir HK, Johnson CJ, Mariotto AB, Turner D, Wilson RJ, Nishri D, et al. Evaluation of North American Association of Central Cancer Registries' (NAACCR) data for use in population-based cancer survival studies. J Natl Cancer Inst Monogr. 2014;49:198-209.
37. Hall S, Schulze K, Groome P, Mackillop W, Holowaty E. Using cancer registry data for survival studies: The example of the Ontario Cancer Registry. J Clin Epidemiol. 2006;59:67-76.
38. Statistics Canada. Profiles of census tracts and census subdivisions, 2001 (Ontario). Ottawa: Author; 2002.
39. US Bureau of the Census. 2000 census of population and housing in California: Summary tape file 3 on CD-ROM. Washington: US Department of Commerce; 2002.
40. Bank of Canada. Currency of Canada: Exchange rates to other major currencies. Available at: http://www.bank-banque-canada.ca. Accessed March 15, 2015
41. American Medical Association. Physician characteristics and distribution in the US: 2000- 2001. Chicago: AMA; 2003.
42. Canadian Institute for Health Information. National Physician Database, 2000-2001 - data release: Methodological notes. Ottawa: CIHI; 2002.
43. McLafferty S, Freeman VL, Barrett RE, Luo L, Shockley A. Spatial error in geocoding physician location data from the AMA Physician Masterfile: Implications for spatial accessibility analysis. Spat Spatiotemporal Epidemiol. 2012;3:31-8.
44. Lix LM, Walker R, Quan H, Nesdole R, Yang J, Chen G, et al. Features of physician services databases in Canada. Chronic Dis Inj Can. 2012;32:186-93.
45. Ferrante JM, McCarthy EP, Gonzalez EC, Lee JH, Chen R, Love-Jackson K, et al. Primary care utilization and colorectal cancer outcomes among Medicare beneficiaries. Arch Intern Med. 2011;171:1747-57.
46. Grumbach K, Chattopadhyay A, Bindman AB. Fewer and more specialized: A new assessment of physician supply in California. Oakland: California Healthcare Foundation; 2009.
47. Hosmer DW, Lemeshow S, Sturdivant RX. Applied logistic regression. 3rd ed. New York: John Wiley & Sons; 2013.
48. Fleiss JL, Levin B, Paik MC. Statistical methods for rates and proportions. 3rd ed. New York: John Wiley & Sons; 2003.
49. Levitz NR, Haji-Jama S, Munro T, Gorey KM, Luginaah IN, Bartfay E, et al. Multiplicative disadvantage of being an unmarried and inadequately insured woman living in poverty with colon cancer: Historical cohort explanation in California. BMC Womens Health. 2015;15:8.
50. Gorey KM, Haji-Jama S, Bartfay E, Luginaah IN, Wright FC, Kanjeekal SM. Lack of access to chemotherapy for colon cancer: Multiplicative disadvantage of being extremely poor, inadequately insured and African American. BMC Health Serv Res. 2014;14:133.
51. Gorey KM, Luginaah IN, Holowaty EJ, Zou GY, Hamm C, Bartfay E, et al. Effects of being uninsured or underinsured and living in extremely poor neighborhoods on colon cancer care and survival in California: Historical cohort analysis, 1996 - 2011. BMC Public Health. 2012;12:897.
52. Gorey KM, Luginaah IN, Bartfay E, Fung KY, Holowaty EJ, Wright FC, et al. Effects of socioeconomic status on colon cancer treatment accessibility and survival in Toronto, Ontario, and San Francisco, California, 1996-2006. Am J Public Health. 2011;101:112-9.
53. Brundisini F, Giacomini M, DeJean D, Vanstone M, Winsor S, Smith A. Chronic disease patients' experiences with accessing health care in rural and remote areas: A systematic review and qualitative meta-synthesis. Ont Health Technol Assess Ser. 2013;13:1-33.
54. Gorey KM, Luginaah IN, Hamm C, Balagurusamy M, Holowaty EJ. The supply of physicians and care for breast cancer in Ontario and California, 1998 to 2006. Can J Rural Med. 2011;16:47-54.
55. Gorey KM, Luginaah IN, Holowaty EJ, Fung KY, Hamm C. Associations of physician supplies with breast cancer stage at diagnosis and survival in Ontario, 1988 to 2006. Cancer. 2009;115:3563-70.
56. Cheung PT, Wiler JL, Lowe RA, Ginde AA. National study of barriers to timely primary care and emergency department utilization among Medicaid beneficiaries. Ann Emerg Med. 2012;60:4-10.
57. Taubman SL, Allen HL, Wright BJ, Baicker K, Finkelstein AN. Medicaid increases emergency-department use: Evidence from Oregon's health insurance experiment. Science. 2014;343:263-8.
58. Baicker K, Taubman SL, Allen HL, Bernstein M, Gruber JH, Newhouse JP, et al. The Oregon experiment: Effects of Medicaid on clinical outcomes. N Engl J Med. 2013;368:1713-22.
59. Jiang M, Sewitch MJ, Barkun AN, Joseph L, Hilsden RJ. Endoscopist specialty is associated with colonoscopy quality. BMC Gastroenterol. 2013;13:78.
60. Patel VB, Nahar R, Murray B, Salner AL. Exploring implications of Medicaid participation and wait times for colorectal screening on early detection efforts in Connecticut: A secret-shopper survey. Conn Med. 2013;77:197-203.
61. Rabeneck L, Paszat LF, Saskin R. Endoscopist specialty is associated with incident colorectal cancer after a negative colonoscopy. Clin Gastroenterol Hepatol. 2010;8:275-9.
62. Bressler B, Paszat LF, Chen Z, Rothwell DM, Vinden C, Rabeneck L. Rates of new or missed colorectal cancers after colonoscopy and their risk factors: A population-based analysis. Gastroenterol. 2007;132:96-102.
63. Urquhart R, Folkes A, Porter G, Kendell C, Cox M, Dewar R, et al. Population- based longitudinal study of follow-up care for patients with colorectal cancer in Nova Scotia. J Oncol Pract. 2012;8:246-53.
64. Klabunde CN, Han PKJ, Earle CC, Smith T, Ayanian JZ, Lee R, et al. Physician roles in the cancer-related follow-up care of cancer survivors. Fam Med. 2013;45:463-74.
65. Maly RC, Liu Y, Diamant AL, Thind A. The impact of primary care physicians on follow-up care of underserved breast cancer survivors. J Am Board Fam Med. 2013;26:628-36.
66. Salz T, Weinberger M, Ayanian JZ, Brewer NT, Earle CC, Lafata JE, et al. Variation in use of surveillance colonoscopy among colorectal cancer survivors in the United States. BMC Health Serv Res. 2010;10:256.
67. Canada S. Population by year, by province and territory, 2012. Author: Ottawa; 2014.
68. US Bureau of the Census. 2010 census of population and housing. Summary tape file 3 by states on CD-ROM. Washington: US Department of Commerce; 2012.
69. Hilman J. 5 years into the Affordable Care Act: California leads the way. Health Access California: Sacramento; 2015.
70. Rice T, Unruh LY, Rosenau P, Barnes AJ, Saltman RB, van Ginneken E. Challenges facing the United States of America in implementing universal coverage. Bull World Health Organ. 2014;92:894-902.
71. Lucia L, Jacobs K, Watson G, Dietz M, Roby DH. Medi-Cal expansion under the Affordable Care Act: Significant increase in coverage with minimal cost to the state. UC Berkeley Center for Labor Research and Education, and UCLA Center for Health Policy Research; 2013.
72. Yin D, Morris CR, Bates JH, German RR. Effect of misclassified underlying cause of death on survival estimates of colon and rectal cancer. J Natl Cancer Inst. 2011;20:1130-3.
73. Hsiao FY, Mullins CD, Onukwugha E, Pandya N, Hanna N. Comparative effectiveness of different chemotherapeutic regimens on survival of people aged 66 and older with stage III colon cancer: A "real world" analysis using Surveillance, Epidemiology, and End Results-Medicare data. J Am Geriatr Soc. 2011;59:1717-23.
74. Lenfant C, Freidman L, Thom T. Fifty years of death certificates: The Framingham Heart Study. Ann Intern Med. 1998;129:1066-7.
75. Brown BW, Brauner C, Minnotte MC. Noncancer deaths in white adult cancer patients. J Natl Cancer Inst. 1993;85:979-87.
76. Driscoll JJ, Rixe O. Overall survival: Still the gold standard. Why overall survival remains the definitive end point in cancer clinical trials. Cancer J. 2009;15:401-5.
77. Saad ED, Buyse M. Overall survival: Patient outcome, therapeutic objective, clinical trial end point, or public health measure? J Clin Oncol. 2012;30:1750-4.
78. Snijders TAB, Boskers RJ. Multilevel analysis: An introduction to basic and advanced multilevel modeling. 2nd ed. Thousand Oaks: Sage; 2012.
79. Austin P. Estimating multilevel logistic regression models when the number of clusters is low: A comparison of different statistical software procedures. Int J Biostats. 2010;6:16.